CHARLENE CONLEY: Open Payments
NPI 1861456758 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 26 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $260 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $171 |
| Novo Nordisk Inc | 2 | $42 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| ABBVIE INC. | 1 | $33 |
| Abbott Laboratories | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: TRELEGY ELLIPTA, SHINGRIX, Ozempic, VOQUEZNA, QULIPTA, FREESTYLE LIBRE 3, CAPLYTA, Kerendia.
Industry payments across NY — which companies pay providers there.
